-
Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial: Authors' reply
CROSSFIRE study investigators, 1 Aug 2024, In: The Lancet Gastroenterology and Hepatology. 9, 8, p. 687-688 2 p.Research output: Contribution to journal › Letter › Academic › peer-review
-
Exploring the predictive potential of programmed death ligand 1 expression in healthy organs and lymph nodes as measured by 18F-BMS986192 PET: pooled analysis of data from four solid tumor types.
Miedema, I. H. C., Pouw, J. E. E., Kwakman, A., Zwezerijnen, G. J. C., Huisman, M. C., Timmer, F. E. F., van de Ven, R., de Gruijl, T. D., Hospers, G. A. P., de Langen, A. J. & Menke-van der Houven van Oordt, C. W., 17 Jun 2024, In: Journal for Immunotherapy of Cancer. 12, 6, e008899.Research output: Contribution to journal › Article › Academic › peer-review
-
Unresectable Intermediate-Size (3–5 cm) Colorectal Liver Metastases: Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation (COLLISION-XL): Protocol of a Phase II/III Multicentre Randomized Controlled Trial
and COLLISION Trial Group, 1 Aug 2023, In: Cardiovascular and interventional radiology. 46, 8, p. 1076-1085 10 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
